# Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL

> **NCT07744737** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Changzhou No.2 People's Hospital** · enrollment: 34 (estimated)

## Conditions studied

- DLBCL - Diffuse Large B Cell Lymphoma
- R-CHOP Chemotherapy
- Pirtobrutinib

## Interventions

- **DRUG:** Pirtobrutinib plus R-CHOP

## Key facts

- **NCT ID:** NCT07744737
- **Lead sponsor:** Changzhou No.2 People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2027-07-30
- **Final completion:** 2029-04-30
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07744737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07744737, "Pirtobrutinib + R-CHOP for Untreated Non-GCB DLBCL". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07744737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*